WuXi Biologics (Cayman), Inc. (WXIBF)
WuXi Biologics Market Cap : 25.25B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 25.25B |
| November 12, 2026 | 25.50B |
| November 11, 2026 | 25.50B |
| November 10, 2026 | 26.07B |
| November 09, 2026 | 25.38B |
| November 06, 2026 | 24.92B |
| November 05, 2026 | 24.92B |
| November 04, 2026 | 24.92B |
| November 03, 2026 | 22.73B |
| November 02, 2026 | 23.34B |
| October 30, 2026 | 23.34B |
| October 29, 2026 | 24.23B |
| October 28, 2026 | 24.23B |
| October 27, 2026 | 22.21B |
| October 26, 2026 | 22.09B |
| October 23, 2026 | 25.95B |
| October 22, 2026 | 21.93B |
| October 21, 2026 | 27.80B |
| October 20, 2026 | 26.12B |
| October 19, 2026 | 26.12B |
| October 16, 2026 | 26.12B |
| October 15, 2026 | 25.44B |
| October 14, 2026 | 25.79B |
| October 13, 2026 | 26.77B |
| October 12, 2026 | 27.72B |
| Date | Value |
|---|---|
| October 09, 2026 | 29.93B |
| October 08, 2026 | 29.44B |
| October 07, 2026 | 30.76B |
| October 06, 2026 | 27.80B |
| October 05, 2026 | 27.80B |
| October 02, 2026 | 27.80B |
| October 01, 2026 | 27.80B |
| September 30, 2026 | 27.80B |
| September 29, 2026 | 27.80B |
| September 28, 2026 | 27.80B |
| September 25, 2026 | 27.80B |
| September 24, 2026 | 24.68B |
| September 23, 2026 | 24.68B |
| September 22, 2026 | 24.68B |
| September 21, 2026 | 24.68B |
| September 18, 2026 | 24.68B |
| September 17, 2026 | 24.68B |
| September 16, 2026 | 24.90B |
| September 15, 2026 | 24.90B |
| September 14, 2026 | 24.90B |
| September 11, 2026 | 24.90B |
| September 10, 2026 | 25.79B |
| September 09, 2026 | 25.79B |
| September 08, 2026 | 25.79B |
| September 04, 2026 | 25.79B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Austar Lifesciences Ltd. | 10.25M |
| Agilent Technologies, Inc. | 49.05B |
| Bio-Rad Laboratories, Inc. | 9.852B |
| Bruker Corp. | 9.406B |
| Azenta, Inc. | 1.906B |
Market Cap Related Metrics
| PE Ratio | 36.07 |
| PS Ratio | 7.597 |
| PEG Ratio | 0.3446 |
| Price to Free Cash Flow | 40.81 |
| Price | 6.15 |
| Earnings Yield | 2.77% |
| PEGY Ratio | 0.3446 |
| Operating PE Ratio | 23.47 |
| Normalized PE Ratio | 38.41 |